A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer
Open Access
- 8 March 2006
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 17 (5) , 827-834
- https://doi.org/10.1093/annonc/mdl033
Abstract
Background: The aim of the study was to compare the longitudinal quality of life (QoL) between chemoradiation with or without surgery in patients with locally advanced squamous resectable esophageal cancer included in a randomized multicenter phase III trial (FFCD 9102). Materials and methods: All patients with locally advanced resectable (T3–4 N0–1 M0) epidermoid or glandular esophageal cancer (n = 451) received induction chemoradiation. Responders (n = 259) were randomized between surgery (arm A) and continuation of chemoradiation (arm B). The Spitzer QoL Index was scored (0–10) at inclusion and at each follow-up, every 3 months during 2 years. QoL at baseline and longitudinal changes were respectively compared with univariate ANOVA and mixed-model analysis of variance for repeated measurements. The time interval between the follow-up was assessed and the same analyses were performed among survivors with 2 years of follow-up. Results: The squamous histology was predominant in both arms. The mean QoL score decreased between baseline and the first follow-up and between the first and the second follow-ups. QoL scores at the first follow-up were comparatively worse in arm A than in arm B (7.52 versus 8.45, P < 0.01), whereas the longitudinal QoL study showed no difference between treatments (adjusted P = 0.26). Furthermore, the longitudinal QoL was not different (adjusted P = 0.23) among survivors with 2 years of follow-up. Conclusions: Among patients responding to induction chemoradiation, surgery and continuation of chemoradiation had the same impact on QoL in patients with locally advanced, resectable esophageal cancer although a significantly greater decrease in the Spitzer Index was observed in the postoperative period.Keywords
This publication has 47 references indexed in Scilit:
- Longitudinal quality of life study in patients with metastatic gastric cancerGastroentérologie Clinique Et Biologique, 2005
- Quality of life after palliative treatment for oesophageal carcinoma – a prospective comparison between stent placement and single dose brachytherapyEuropean Journal Of Cancer, 2004
- Multivariate Prognostic Factor Analysis in Locally Advanced and Metastatic Esophago-Gastric Cancer—Pooled Analysis From Three Multicenter, Randomized, Controlled Trials Using Individual Patient DataJournal of Clinical Oncology, 2004
- Evaluating the quality of life of cancer patients: assessments by patients, significant others, physicians and nursesBritish Journal of Cancer, 1999
- Assessing Quality of Life in Clinical ResearchJournal of Clinical Epidemiology, 1999
- Development of an EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancerEuropean Journal Of Cancer, 1996
- Quality of life measurement in patients with oesophageal cancer.Gut, 1995
- Critical review of the international assessments of health-related quality of lifeQuality of Life Research, 1993
- Quality of Life End Points in Cancer Clinical Trials: Review and RecommendationsJNCI Journal of the National Cancer Institute, 1989
- Measuring the quality of life of cancer patientsJournal of Chronic Diseases, 1981